Renal Cancer - Results from #6120

Resistance to Antiangiogenic Therapy Is Associated with an Immunosuppressive Tumor Microenvironment in Metastatic Renal Cell Carcinoma August 4, 2015

Prognosis of patients with metastatic renal cell carcinoma and pancreatic metastases August 4, 2015

Intratumoral CD14+ Cells and Circulating CD14+HLA-DRlo/neg Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma July 31, 2015

How can we improve prognostic models in renal cell carcinoma? July 31, 2015

Role of cytoreductive nephrectomy for Japanese patients with primary renal cell carcinoma in the cytokine and targeted therapy era July 31, 2015

[Ablative treatments in localised renal cancer: Literature review in 2014] July 31, 2015

Preoperative Anemia as an Independent Prognostic Indicator of Papillary Renal Cell Carcinoma July 31, 2015

Metastases to the kidney: a comprehensive analysis of 151 patients from a tertiary referral centre July 30, 2015

Preoperative multivariable prognostic models for prediction of survival and major complications following surgical resection of renal cell carcinoma with suprahepatic caval tumor thrombus July 29, 2015

Decreased PBRM1 expression predicts unfavorable prognosis in patients with clear cell renal cell carcinoma July 29, 2015

A case of metastatic renal cell carcinoma and bile duct carcinoma treated with a combination of sunitinib and gemcitabine July 29, 2015

Kidney cancer: current and novel treatment options July 29, 2015

Survival among Black and White patients with renal cell carcinoma in an equal-access health care system July 27, 2015

Sunitinib Treatment Exacerbates Intratumoral Heterogeneity in Metastatic Renal Cancer July 26, 2015

Immunotherapy in Metastatic Renal Cell Carcinoma: A Comprehensive Review July 24, 2015

Assessing the impact of mass media public health campaigns:'Be clear on cancer: Blood in pee' a case in point - Abstract July 21, 2015

Trial Watch: Therapeutic vaccines in metastatic renal cell carcinoma July 20, 2015

CheckMate -025, a Pivotal Phase III Opdivo (nivolumab) Renal Cell Cancer Trial, Stopped Early July 20, 2015

Thrombocytosis as a prognostic factor in patients with renal cell carcinoma: A meta-analysis of literature - Abstract July 17, 2015

Partial nephrectomy for metastatic renal cell carcinoma: Where do we stand? - Abstract July 17, 2015

Page 307 of 459